LBGCX
Price
$37.49
Change
-$1.34 (-3.45%)
Updated
Feb 21 closing price
Net Assets
290.53M
PMBPX
Price
$44.27
Change
-$0.76 (-1.69%)
Updated
Feb 21 closing price
Net Assets
30.08B
Ad is loading...

LBGCX vs PMBPX

Header iconLBGCX vs PMBPX Comparison
Open Charts LBGCX vs PMBPXBanner chart's image
ClearBridge Mid Cap Growth C
Price$37.49
Change-$1.34 (-3.45%)
VolumeN/A
Net Assets290.53M
Principal MidCap R5
Price$44.27
Change-$0.76 (-1.69%)
VolumeN/A
Net Assets30.08B
LBGCX vs PMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LBGCX vs. PMBPX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBGCX is a Buy and PMBPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 30.1B vs. LBGCX (291M). LBGCX (0.00) and PMBPX (0.00) have matching dividends . LBGCX was incepted earlier than PMBPX: LBGCX (14 years) vs PMBPX (24 years). LBGCX is a more actively managed with annual turnover of: 14.00 vs. PMBPX (10.10). PMBPX has a lower initial minimum investment than LBGCX: PMBPX (0) vs LBGCX (1000). LBGCX annual gain was more profitable for investors over the last year : 23.61 vs. PMBPX (17.07). LBGCX return over 5 years is better than : 41.48 vs. PMBPX (38.64).
LBGCXPMBPXLBGCX / PMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years24 years-
Gain YTD7.9764.533176%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets291M30.1B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year23.6117.07138%
Returns for 3 years27.6429.5194%
Returns for 5 years41.4838.64107%
Returns for 10 years69.1597.5171%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY17.330.44
+2.61%
Bally's Corporation
BIO285.631.90
+0.67%
Bio-Rad Laboratories IncClass A
GPUS3.150.02
+0.64%
Hyperscale Data Inc
PTGX38.49-0.04
-0.10%
Protagonist Therapeutics
MIST2.06-0.07
-3.29%
Milestone Pharmaceuticals